FML Forte — Cigna
inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe
Preferred products
- generic dexamethasone sodium phosphate ophthalmic solution 0.1%
- generic difluprednate ophthalmic emulsion 0.05%
- generic fluorometholone ophthalmic suspension 0.1%
- generic prednisolone acetate ophthalmic suspension 1%
- generic prednisolone sodium ophthalmic solution 1%
Initial criteria
- Patient has tried two Step 1 Products
Approval duration
1 year